España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Incyte
INCY
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$68.84
1.78
2.65%
At close: -
$68.82
-0.02
-0.03%
After Hours: Dec 20, 4:36 PM EDT
Get Report
Comment
Incyte (INCY) Forecast
News
Earnings
Incyte (INCY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Incyte (NASDAQ:INCY) Stock
Incyte Stock (NASDAQ: INCY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 19, 2024
The Analyst Verdict: Incyte In The Eyes Of 15 Experts
Benzinga Insights
Wells Fargo Maintains Equal-Weight on Incyte,...
Benzinga Newsdesk
Tuesday, December 10, 2024
Incyte's Late-Breaking ASH 2024 Data Show Taf...
Benzinga Newsdesk
Saturday, December 07, 2024
Incyte Announced Results From Phase 3 Trial E...
Benzinga Newsdesk
Monday, November 25, 2024
Incyte To Present Late-Breaking Tafasitamab D...
Benzinga Newsdesk
Sunday, November 24, 2024
Target, Alibaba And Temu Parent PDD Are Among Top 10 Large-Cap Losers Last Week (Nov 18-Nov 22): Are The Others In Your Portfolio?
Lekha Gupta
Tuesday, November 19, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Gold Moves Higher; Medtronic Posts Upbeat Results
Avi Kapoor
Stocks Move Higher, Walmart Hits Record High, Natural Gas Reaches 5-Month Peak: What's Driving Markets Tuesday?
Piero Cingari
Incyte Shares Resume Trade
Benzinga Newsdesk
Watching Incyte; Sky News City Editor Mark Kl...
Benzinga Newsdesk
Incyte Shares Halted On Circuit Breaker To Th...
Benzinga Newsdesk
What's Going On With Incyte Shares Tuesday?
Dylan Berman
Aecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, Analyst Flags Challenges
Vandana Singh
Nasdaq Gains 100 Points; Lowe's Earnings Beat Views
Avi Kapoor
RBC Capital Maintains Sector Perform on Incyt...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Neutral on Incyt...
Benzinga Newsdesk
Incyte shares are trading lower after the com...
Benzinga Newsdesk
Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, November 18, 2024
Incyte Says Data From Phase 2 Study Evaluatin...
Benzinga Newsdesk
Incyte To Pause Enrollment In Ongoing Phase 2...
Benzinga Newsdesk
Friday, November 15, 2024
Watching Incyte; Traders Circulate Research R...
Benzinga Newsdesk
Thursday, November 14, 2024
Cracking The Code: Understanding Analyst Reviews For Incyte
Benzinga Insights
RBC Capital Maintains Sector Perform on Incyt...
Benzinga Newsdesk
Wednesday, November 13, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Thursday, November 07, 2024
Watching Incyte; Shares See Volume As Traders...
Benzinga Newsdesk
Wednesday, October 30, 2024
Incyte's Jakafi Demand Is Strong, Analyst Upgrades Stock
Vandana Singh
Wells Fargo Maintains Equal-Weight on Incyte,...
Benzinga Newsdesk
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Vandana Singh
Citigroup Maintains Buy on Incyte, Raises Pri...
Benzinga Newsdesk
Morgan Stanley Maintains Equal-Weight on Incy...
Benzinga Newsdesk
Goldman Sachs Maintains Neutral on Incyte, Ra...
Benzinga Newsdesk
RBC Capital Maintains Sector Perform on Incyt...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Incyte, R...
Benzinga Newsdesk
JP Morgan Maintains Neutral on Incyte, Raises...
Benzinga Newsdesk
This Alphabet Analyst Turns Bullish; Here Are Top 5 Downgrades For Wednesday
Avi Kapoor
BMO Capital Reiterates Underperform on Incyte...
Benzinga Newsdesk
B of A Securities Upgrades Incyte to Buy, Rai...
Benzinga Newsdesk
Tuesday, October 29, 2024
Incyte Clocks Mixed Q3 Earnings, But Analyst Sees A Strong Quarter For Jakafi And Opzelura
Vandana Singh
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Incyte shares are trading higher after the co...
Benzinga Newsdesk
Incyte Expects 2024 Jakafi Net Product Revenu...
Benzinga Newsdesk
Incyte Q3 2024 Adj. EPS $1.07 Misses $1.09 Es...
Benzinga Newsdesk
Wednesday, October 23, 2024
Peeling Back The Layers: Exploring Incyte Through Analyst Insights
Benzinga Insights
JP Morgan Maintains Neutral on Incyte, Raises...
Benzinga Newsdesk
Wednesday, October 16, 2024
Incyte Announces Health Canada Approval Of OP...
Benzinga Newsdesk
Thursday, October 10, 2024
A Look Into Incyte Inc's Price Over Earnings
Benzinga Insights
Wells Fargo Maintains Equal-Weight on Incyte,...
Benzinga Newsdesk
Tuesday, October 01, 2024
Assessing Incyte: Insights From 11 Financial Analysts
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch